Abstract
EUS-guided FNA (EUS-FNA) is an established efficient technique for sampling pancreatic mass lesions. However, EUS-FNA has some limitations. The diagnostic accuracy of EUS-FNA is impacted by the availability of a cytopathologist to render an on-site diagnosis and its sensitivity for diagnosing malignancy is low in the setting of associated chronic pancreatitis and as well as for certain neoplasms (i.e. stromal cell tumors and lymphomas), for which it may be difficult to diagnose without histologic samples.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
